/
Company Overview Pro-Dex, Inc. ( Company, Pro-Dex, we, our, us ) specializes in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and craniomaxillofacial ( CMF ) markets. We have patented adaptive torque-limiting technology and proprietary sealing solutions which appeal …
$57.38
$1.70 (-2.88%)
EOD Jul 17, 2026
16.05% operating margin is respectable but not wide. ROIC at 14.19%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.
Revenue up 23.7% YoY with margins expanding 2.7pp.
Even for strong businesses, today's 16x P/E means the stock needs to keep delivering. There's no margin of safety if growth disappoints.
16.0x earnings. Valuation is in a reasonable range. The main question is whether the business can re-accelerate or if current trajectory is already priced in.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$75M
▲ +23.7% YoY
Net Income (TTM)
$12M
▲ +322.1% YoY
Op. Margin
14.48%
▲ +2.7pp YoY
ROIC
10.99%
▲ +0.6pp YoY
Cash Flow & Balance Sheet
FCF
N/A
Op. Cash Flow (TTM)
$7M
▼ -127.0% YoY
Net Debt
$17M
Cash & Equiv.
$8M
3Y CAGR: +16.6%
Continue Research
At a P/E of 16.0, Pro-Dex (PDEX)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Pro-Dex scores 54/100 on Intrinsiqq's quality scorecard (a mixed business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full . This is analysis, not investment advice.
Pro-Dex scores 54 out of 100 on Intrinsiqq's quality score, a weighted blend of 6 metrics each scored 0 to 100, which makes it a mixed business on these measures. Recent fundamentals include a 14.5% operating margin and a 11.0% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. you should weigh PDEX's valuation and scores 54/100 on quality (mixed). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.